NOVOB/N fundamentals
NOVO NORDISK A/S revenue breakdown overview
NOVO NORDISK A/S revenue for the last year amounted to 837.97 B MXN, the most of which — 784.19 B MXN — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 540.80 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO NORDISK A/S 483.05 B MXN, and the year before that — 320.64 B MXN.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
210.00 B
420.00 B
630.00 B
840.00 B
Diabetes and Obesity Care
Rare Disease
Currency: MXN
2017
2018
2019
2020
2021
2022
2023
2024
Diabetes and Obesity Care
353.80 B
381.67 B
437.78 B
540.80 B
784.19 B
Rare Disease
61.99 B
60.27 B
57.50 B
43.15 B
53.78 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
210.00 B
420.00 B
630.00 B
840.00 B
United States
EMEA
Rest of the World
China
Canada
Europe
Africa, Asia, Middle East and Oceania
Japan & Korea
Latin America
Currency: MXN
2017
2018
2019
2020
2021
2022
2023
2024
United States
189.39 B
197.77 B
236.94 B
320.64 B
483.05 B
EMEA
112.33 B
118.35 B
123.81 B
127.89 B
174.29 B
Rest of the World
57.15 B
62.19 B
71.10 B
70.59 B
96.17 B
China
46.13 B
50.28 B
45.37 B
41.95 B
53.39 B
Canada
10.79 B
13.35 B
18.06 B
22.87 B
31.08 B
Europe
—
—
—
—
—
Africa, Asia, Middle East and Oceania
—
—
—
—
—
Japan & Korea
—
—
—
—
—
Latin America
—
—
—
—
—